Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

European orphan product designation granted to algenpantucel-L

Nov. 15, 2012

Transgene and EORTC to collaborate on phase IIb trial of TG-4001

Nov. 15, 2012

Interim results for CVax show encouraging immune response

Nov. 15, 2012

Antitumor efficacy demonstrated for PF-05082566 in mouse model

Nov. 15, 2012

Colby and MannKind sign agreement to develop cancer immunotherapy products

Nov. 14, 2012

Interim results presented for a peptide-based cancer vaccine

Nov. 13, 2012

Cadila Pharmaceuticals presents clinical results for CADI-05 in bladder cancer

Nov. 8, 2012

FDA grants priority review to trastuzumab emtansine NDA

Nov. 8, 2012

First patient enrolled in phase I/IIa trial of PAT-SM6

Nov. 8, 2012

Preliminary results demonstrate good safety and efficacy for 3F8 + NK cells in neuroblastoma

Nov. 6, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026